SCHEMBL28864240

SCHEMBL28864240

O=C(Oc1ccncc1)N1CCCCC1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.76
POLB P06746 1/20 0.76
SMN1; SMN2 Q16637 7/20 0.61
KMT2A Q03164 6/20 0.61
MEN1 O00255 5/20 0.61
LMNA P02545 2/20 0.61
NPSR1 Q6W5P4 1/20 0.61
MAPT P10636 3/20 0.59
NPC1 O15118 3/20 0.59
HTT P42858 2/20 0.59
RAB9A P51151 2/20 0.59
HSD17B10 Q99714 1/20 0.54
ATM Q13315 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
TSHR P16473 5/20 0.52
CYP2C9 P11712 5/20 0.52
CYP2D6 P10635 3/20 0.52
HIF1A Q16665 3/20 0.52
MAPK1 P28482 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30632968 0.98 ALDH1A1 (0.72) ALDH1A1POLBSMN1; SMN2KMT2AMEN1
SCHEMBL26123763 0.95 ALDH1A1 (0.67) ALDH1A1POLBSMN1; SMN2KMT2AMEN1
SCHEMBL7361067 0.84 ALDH1A1 (0.53) ALDH1A1POLBSMN1; SMN2KMT2AMEN1
SCHEMBL28864238 0.83 ALDH1A1 (0.51) ALDH1A1POLBSMN1; SMN2KMT2AMEN1
SCHEMBL11480252 0.81 ALDH1A1 (0.81) ALDH1A1POLBSMN1; SMN2KMT2AMEN1
SCHEMBL6882525 0.81 ALDH1A1 (0.81) ALDH1A1POLBSMN1; SMN2KMT2AMEN1
SCHEMBL28670891 0.81 ALDH1A1 (0.64) ALDH1A1POLBSMN1; SMN2KMT2AMEN1
SCHEMBL27722718 0.80 ALDH1A1 (0.62) ALDH1A1POLBSMN1; SMN2KMT2AMEN1
SCHEMBL30480290 0.80 ALDH1A1 (0.47) ALDH1A1POLBSMN1; SMN2KMT2AMEN1
SCHEMBL1578826 0.79 ALDH1A1 (0.78) ALDH1A1POLBSMN1; SMN2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108602816-A Compounds for treating cystic fibrosis 艾伯维公司 2018-09-28 CN disclosed